Related Experiment Videos
Is there a right hemi-hyper-dopaminergic psychosis?
1Neuropsychiatric Special Evaluation Unit, VA Medical Center, North Little Rock, AR 72114.
Schizophrenia Research
|July 1, 1989
Summary
A small subgroup of schizophrenia patients may have right striatal hyper-dopaminergia, indicated by specific neurological signs and dopamine receptor differences. This finding suggests a potential biomarker for this patient subset.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Schizophrenia diagnosis relies on DSM-III-R criteria.
- Dopamine system dysregulation is implicated in schizophrenia.
- Heterogeneity exists within schizophrenia patient populations.
Purpose of the Study:
- To identify a specific subgroup of schizophrenia patients with underlying right striatal hyper-dopaminergia.
- To outline objective clinical and neurobiological markers distinguishing this subgroup.
Main Methods:
- Selective review of existing literature and clinical observations.
- Analysis of objective signs associated with dopamine system activity.
- Comparison of dopamine receptor densities between brain hemispheres.
Main Results:
- A subgroup exhibits asymmetric neuroleptic-induced parkinsonism (right-sided).
- This subgroup shows asymmetric tardive dyskinesia (left-sided) and leftward turning tendency.
- Subclinical right hemi-space sensory neglect and greater right than left striatal dopamine receptor density are observed.
Conclusions:
- Right striatal hyper-dopaminergia is a potential underlying mechanism in a distinct schizophrenia subgroup.
- Asymmetric neurological signs and dopamine receptor distribution may serve as biomarkers.
- Further research can explore targeted treatments for this identified subgroup.